What Advanced Medical Solutions does

Advanced Medical Solutions Group plc is a UK-headquartered, publicly listed (LSE:AMS) medical device company founded in 1991 that develops and manufactures innovative tissue-healing technologies for the global wound care and surgical markets. Its product portfolio spans two business units: a surgical unit offering tissue adhesives and sealants (LiquiBand, LiquiBandFix8, Seal-G, InteguSeal microbial sealant), biosurgical solutions (RESORBA haemostats, bone substitutes, regenerative and antibiotic collagens, resorbable fixation systems), and sutures, clips and vascular temporary occlusion devices; and a wound care unit offering exudate management dressings (ActivHeal alginates, silicone foam, high-performance dressings) and infection control products (silver-based dressings, PHMB foam, Tri-Go moisture-wicking fabric). Underlying technology combines proprietary material science with applicator device design developed in collaboration with surgeons and Key Opinion Leaders, backed by seven ISO 13485/MDSAP-certified manufacturing sites across the UK, Germany, France, the Netherlands, the Czech Republic and Israel.

The company sells globally via a hybrid model: direct sales forces in the UK, Germany, Austria, the Czech Republic and Russia, complemented by multinational and regional distribution partners — including strategic anchors Kimberly-Clark (InteguSeal) and Stryker (LiquiBand cranio-maxillofacial) — reaching more than 100 countries. Revenue is generated primarily through B2B hardware sales of branded products (LiquiBand, RESORBA, LiquiBandFix8, Seal-G, ActivHeal, Peters Surgical) plus OEM contract manufacturing for the medical device industry. End customers are hospitals, surgical centers and NHS Trusts, with ActivHeal positioned as a value proposition for NHS procurement. The portfolio has been built through an active M&A programme, most notably the 2019 cluster of bolt-ons (Sealantis, Biomatlante, Raleigh Coatings, AFS Medical, Connexicon) and the July 2024 acquisition of Peters Surgical from Eurazeo for €141.4 million, which drove FY25 revenue to £228.9M (up 29%). As of June 2026, the company is subject to a recommended £715 million cash acquisition by H.B. Fuller at £2.85 per share, pending shareholder and regulatory approvals.

Name

Advanced Medical Solutions

Legal name

Advanced Medical Solutions Group plc

Website

https://admedsol.com

Company type

Public

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

Advanced Medical Solutions is a UK-listed medical device company (LSE:AMS) that develops and manufactures tissue adhesives, sealants, biosurgicals, sutures and advanced wound care dressings, selling globally to hospitals and surgical centers across more than 100 countries.

Ownership category

akta.pro rank

Product category

Medical Devices - Wound Care and Surgical Tissue Healing

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

akta.pro secondary industries

Wound Care & Ulcer Management (HLAKACAN), Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Wound Care & Diabetic Foot Infection (HLAKAGAK)

Keywords

• Tissue adhesives sealants
• Surgical wound care
• Biosurgical medical devices
• Sutures surgical supplies
• Advanced wound dressings

Headquarters

HQ city

Winsford

HQ country

United Kingdom

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Surgical Products Sales: AMS generates revenue through the sale of innovative tissue-healing technologies including tissue adhesives, sutures, haemostats, internal fixation devices, internal sealants, and biosurgical products marketed under LiquiBand, RESORBA, LiquiBandFix8, and Seal-G brands. Surgical products drive the lion's share of group revenues.
2. Wound Care Dressings Sales: Revenue from wound care products including silver alginates, alginates and foams sold through ActivHeal brand as well as under white label arrangements
3. Contract Manufacturing: AMS operates as a leading supplier of components to the medical device industry as an OEM, contributing to advancements in healthcare by supplying critical components

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

AMS develops, manufactures, and sells innovative tissue-healing technologies for the global wound care and surgical markets. Its portfolio spans tissue adhesives and sealants, biosurgical products (haemostats, bone substitutes, regenerative collagens, resorbable fixation systems), sutures and vascular occlusion devices, and advanced wound care dressings (alginates, silicone foams, silver and PHMB antimicrobial dressings). The company also operates an OEM contract manufacturing business supplying medical device components.

Product overview

Advanced Medical Solutions Group plc is a world-leading independent developer and manufacturer of innovative tissue-healing technologies. The company's product portfolio is organized into surgical and woundcare categories. Surgical products include tissue adhesives and sealants (LiquiBand, LiquiBandFix8, Seal-G, InteguSeal), biosurgical solutions (RESORBA brand covering haemostats, bone substitutes, collagens, resorbable fixation systems), and sutures, clips and vascular occlusion devices. Woundcare products include exudate management dressings (ActivHeal brand - alginates, silicone foams, high performance dressings) and infection control products (silver-based dressings, PHMB foam, Moisture Wicking Fabric with Tri-Go). The portfolio was significantly expanded through the 2024 acquisition of Peters Surgical, adding to AMS's global surgical product capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• LiquiBand: Tissue adhesives brand for wound closure and surgical applications
• RESORBA
• LiquiBandFix8
• Seal-G
• ActivHeal
• Peters Surgical
• InteguSeal
• Tri-Go

Products and services

• Adhesives & Sealants (LiquiBand) Comprehensive range of tissue adhesives and sealants (LiquiBand brand) including internal adhesives, large incision adhesives, microbial sealants (InteguSeal), surgical sealants, and traditional topical skin adhesives. Used to protect incisions, secure internal structures, and create protective barriers.
• Biosurgical Solutions (RESORBA) Fastest growing segment of AMS surgical business covering wound healing, cardiovascular, orthopaedics and dental segments, including haemostats, bone substitutes, regenerative collagens, antibiotic collagens, and resorbable fixation systems under the RESORBA brand.
• Sutures, Clips & Vascular Temporary Occlusion (Peters Surgical) Surgical sutures, clips, and vascular temporary occlusion devices for repairing and closing tissues, including laparoscopic instruments and other surgical devices from the Peters Surgical brand.
• Exudate Management Wound Care (ActivHeal)

Quantifiable outcome

• Revenue growth of 29% to £228.9M in FY25
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• StrykercoreChannel Partner/ Reseller/ Distributor · 9 July 2009Global partnership for distribution of LiquiBand products in cranio-maxillofacial surgery, providing AMS access to Stryker's surgical network.
• Kimberly-ClarkcoreChannel Partner/ Reseller/ Distributor · 27 May 2009Kimberly-Clark markets InteguSeal microbial sealant worldwide. This partnership leverages Kimberly-Clark's global distribution network to reach hospitals and surgical centers with AMS's SSI reduction technology.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Smith & Nephew: Global medical devices business with a sizable Advanced Wound Management franchise and Sports Medicine/Surgical portfolio. Directly comparable to AMS in alginate, foam, and antimicrobial dressings, as well as surgical wound closure adjacencies.
• Mölnlycke Health Care: Privately held Swedish medtech leader in wound care (Mepilex, Mepitel) and surgical solutions (single-use instruments, staff clothing). Direct overlap with AMS's exudate management dressings and surgical adhesives.
• B. Braun: German family-owned medical device manufacturer with global surgical sutures, wound closure, and infection prevention portfolios. Direct overlap with Peters Surgical sutures and AMS surgical adhesives and biosurgicals.
• Ethicon (Johnson & Johnson MedTech): J&J's surgical franchise, the global category leader in sutures, topical skin adhesives (DERMABOND), and haemostats. The dominant incumbent competing against LiquiBand, Peters Surgical sutures, and AMS haemostats.
• Teleflex Incorporated: US-listed diversified medical device company with surgical sutures, hemostatic and sealant products, and vascular access. Overlaps with Peters Surgical sutures/clips and AMS Seal-G internal sealants.
• 3M Health Care: Global conglomerate with a Health Care division spanning advanced wound care dressings (Tegaderm), skin closures, and surgical supplies. Direct overlap with AMS exudate management and infection control dressings via large distribution channels.

Direct peers

• ConvaTec Group: UK-listed specialist in advanced wound care, ostomy, continence, and infusion care with a strong portfolio of alginate, hydrocolloid, and antimicrobial dressings. Closely comparable to AMS's ActivHeal wound care franchise and infection control dressings.
• Integra LifeSciences: US-listed specialty medical device company with tissue technologies (DuraGen, Integra dermal matrix) and a dedicated Wound Care franchise. Closely comparable to AMS's regenerative collagens, skin substitutes, and advanced wound dressings.
• Coloplast: Danish specialist in wound care, ostomy, continence, and interventional urology with Biatain foam and antimicrobial dressings. Comparable to AMS wound care portfolio and similar European specialty medical device business model.
• Organogenesis Holdings: US-listed regenerative medicine company focused on advanced wound care (Apligraf, Dermagraft) and surgical biologics. Closely comparable to AMS's biosurgicals, regenerative collagens, and skin substitute adjacencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/advanced-medical-solutions

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Medical Solutions